CHILDREN'S HOSPITAL & RESEARCH CENTER OAKLAND Patent applications |
Patent application number | Title | Published |
20150328035 | Variable Pressure Upper Torso Braces and Methods Related Thereto - Upper torso braces to correct deformities in the upper torso of a patient are provided. The upper torso braces include a brace structure adapted to be maintained around an upper torso of an individual and to restrict outward expansion, and a variable force applicator coupled to the brace structure and positioned to contact and apply varying pressure to a target location on the upper torso. The brace structure is configured to restrict outward expansion and to provide a counteracting force for the variable force applicator during application of the variable pressure to the target location. In some instances, the upper torso braces may include a control element to adjust an amount of pressure provided by the variable force applicator to the target location. Methods of correcting a deformity on an upper torso with the upper torso braces are also provided. | 11-19-2015 |
20140220632 | Engineered Sequences to Facilitate Expression of Antigens in Neisseria and Methods of Use - The present disclosure generally provides non-naturally-occurring polynucleotide sequences that facilitate high-level expression of one or more gene products (e.g., polypeptides, RNA) of interest in | 08-07-2014 |
20130225670 | Methods of Treating Asthma Using Statins - The present disclosure generally provides methods for assessing a subject's responsiveness to a statin therapy, and selection of a statin dose based upon such methods. The disclosure further provides methods for treating asthma by administering a statin therapy. | 08-29-2013 |
20100047163 | Synthetic LDL as Targeted Drug Delivery Vehicle - The present invention provides a synthetic LDL nanoparticle comprising a lipid moiety and a synthetic chimeric peptide so s to be capable of binding the LDL receptor. The synthetic LDL nanoparticle of the present invention is capable of c incorporating and targeting therapeutics for diseases associated with the expression of the LDL receptor. The invention further provides methods of using such synthetic LDL nanoparticles. | 02-25-2010 |